NYSE - Nasdaq Real Time Price USD

Hims & Hers Health, Inc. (HIMS)

Compare
26.63 +1.43 (+5.67%)
At close: January 3 at 4:00:02 PM EST
26.81 +0.18 (+0.68%)
After hours: January 3 at 7:59:53 PM EST
Loading Chart for HIMS
DELL
  • Previous Close 25.20
  • Open 25.11
  • Bid 26.72 x 800
  • Ask 26.75 x 800
  • Day's Range 25.08 - 26.75
  • 52 Week Range 8.14 - 35.02
  • Volume 6,726,701
  • Avg. Volume 16,988,275
  • Market Cap (intraday) 5.818B
  • Beta (5Y Monthly) 1.06
  • PE Ratio (TTM) 60.52
  • EPS (TTM) 0.44
  • Earnings Date Feb 24, 2025 - Feb 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 25.21

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

www.forhims.com

1,046

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HIMS

View More

Performance Overview: HIMS

Trailing total returns as of 1/3/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

HIMS
5.80%
S&P 500
0.60%

1-Year Return

HIMS
176.24%
S&P 500
25.29%

3-Year Return

HIMS
306.56%
S&P 500
24.68%

5-Year Return

HIMS
168.99%
S&P 500
82.40%

Compare To: HIMS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HIMS

View More

Valuation Measures

As of 1/3/2025
  • Market Cap

    5.82B

  • Enterprise Value

    5.58B

  • Trailing P/E

    60.52

  • Forward P/E

    54.95

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.88

  • Price/Book (mrq)

    13.22

  • Enterprise Value/Revenue

    4.49

  • Enterprise Value/EBITDA

    98.52

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.15%

  • Return on Assets (ttm)

    5.66%

  • Return on Equity (ttm)

    26.35%

  • Revenue (ttm)

    1.24B

  • Net Income Avi to Common (ttm)

    101.26M

  • Diluted EPS (ttm)

    0.44

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    254.07M

  • Total Debt/Equity (mrq)

    2.58%

  • Levered Free Cash Flow (ttm)

    126.81M

Research Analysis: HIMS

View More

People Also Watch